| Independent Reports (Showing 1 to 10 of 10) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 23-Nov-09 | Reuters Investment Profile | N/A | Alfacell Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $20 | View Abstract |
| 23-Nov-09 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 | $299 | View Abstract |
| 23-Nov-09 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 | $199 | View Abstract |
| 20-Nov-09 | Ford Investor Services, Inc. | N/A | Value Graph: ALFACELL -- ACEL | 1 | $4 | View Abstract |
| 20-Nov-09 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ACHN , ACEL , BDSI , IMMP , INO -- DRUGS | 3 | $4 | View Abstract |
| 14-Nov-09 | Pechala's Reports | Frantisek Pechala | ALFACELL CP (ACEL=US) 12-months forecast | 1 | $15 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for BIOTECHNOLOGY | 18 | $49 | View Abstract |
| 30-Mar-09 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for ACEL | 13 | $25 | View Abstract |
| 28-Mar-09 | Pechala's Reports | Lubomir Pechala | ALFACELL CP (ACEL=US) 2-weeks forecast | 1 | $10 | View Abstract |
| 28-Mar-09 | Standard & Poor's Quantitative Report | N/A | Alfacell Corp | 5 | $25 | View Abstract |